MiMedx Group, Inc. is an international entity in the realm of regenerative medicine. Its area of expertise is tissue regeneration, which it both develops and distributes, along with related biopharmaceutical products.
MiMedx operates in the healthcare sector, specifically within the biotechnology and medical research industry. Through its commitment to revolutionising tissue regeneration, the company provides solutions to injured patients including patent protected skin grafts for wounds and burns.
Keep up to date on the latest share price changes by adding MDXG stock to your eToro watchlist